Machine learning analysis of pretreatment CT radiomics features predicts risk of medication-related osteonecrosis of the jaw (MRONJ) in patients prior to bone resorption inhibitor therapy.
Key Details
- 1Retrospective study at Hiroshima University analyzed pretreatment CT scans of 94 patients.
- 2Radiomics features from jawbone CTs were used with machine learning models (RF, SVM, MLP).
- 3Models combining cancellous and cortical bone features significantly improved prediction—AUCs rose to as high as 0.931.
- 4The best model identified 88.6% of future MRONJ cases and 88.6% of controls.
- 5MRONJ affects up to 15% of patients on bone resorption inhibitors and is difficult to treat once developed.
- 6Study was limited by its retrospective nature and lack of comprehensive dental data.
Why It Matters
If validated, radiomics-based AI could enable early identification of high-risk patients, supporting tailored preventive strategies before starting bone resorption inhibitor treatment and potentially reducing severe, life-altering MRONJ complications.
Source
EurekAlert
Related News
•EurekAlert
AI Model Combines ECG and Blood Tests to Spot Heart Transplant Rejection
An AI model integrating ECG data and blood biomarkers predicts heart transplant rejection with high specificity, reducing the need for invasive biopsies.
•EurekAlert
EU Launches €20M CHAIN Project to Advance AI in Cardiovascular Care
The EU launches the CHAIN initiative to build a validated, federated AI ecosystem for cardiovascular health.
•EurekAlert
NIH Grant Funds AI Tool for Lung Cancer Discovery at Weill Cornell
Dr. Olivier Elemento receives an NIH Pioneer Award to develop an AI-human hybrid platform for cancer research, initially focusing on lung cancer using imaging and tissue data.